Insights

Security is a problem, right? Well there's a radically different way to view it – as a positive force capable of putting clear water between you and your competitors. 

The medical implant industry is set to grow from $5bn in 2017 to $16.3bn by 2022. But there are tensions to understand and hurdles to overcome for innovators intent on taking advantage.

Patient monitoring is an inherent part of patient management. Intermittent and continuous measurements have a range of uses, from defining disease states and characterising progression to informing therapeutic approaches and...

Products are incorporating increasingly complex technology, putting greater pressure on the supply chain. As a result, gaps are forming and the risk to reputations and revenues is growing through issues such as...

Intravitreal Injection Syringe: It is merely a pre-filled syringe, but is it?

As we enter 2021, the drive to adopt remote monitoring telemedicine techniques continues to gather pace. With the effects of the pandemic still reverberating around the world, healthcare providers are increasingly turning to a remote model to reduce infection risks.

Now you’ve got a talented team together, surely it’s time to push on to design and build your device? Not quite. In the latest in his series of articles, our VP Surgical Robotics & Advanced Surgical Systems Andrew Savarese explains the crucial importance of system architecture, the vital blueprint for project efficiency… 

The rapid, at home COVID-19 antigen test from digital diagnostics company Ellume features core technology from Cambridge Consultants. Read how this FDA approved test is set to be a game-changer in the global pandemic.

Telemedicine is where telecommunication and healthcare converge.

The ophthalmology world is welcoming a new wave of sophisticated implant technology designed to transform diagnosis and treatment.

Sustainability emerged as a hot and emotive topic at this year’s Drug Delivery to the Lungs (DDL) conference, read Donal Taylor's thoughts on other key trends that emerged.

Matt Garwood challenges the medical device development status quo. If we embrace a bold, comprehensive response that begins at the concept stage and ends with the device user, it is possible to challenge conventional thinking and change for the better.